Chemoinformaics analysis of trans-carveol acetate
| Molecular Weight | 194.274 | nRot | 2 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 8 |
| Exact Molecular Weight | 194.131 | nRing | 1 |
| Solubility: LogS | -2.606 | nHRing | 0 |
| Solubility: LogP | 2.993 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 33.6463 |
| nHD | 0 | BPOL | 20.6617 |
| QED | 0.499 |
| Synth | 3.592 |
| Natural Product Likeliness | 2.648 |
| NR-PPAR-gamma | 0.029 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.003 |
| HIA | 0.012 |
| CACO-2 | -4.312 |
| MDCK | 0.000024 |
| BBB | 0.978 |
| PPB | 0.671867 |
| VDSS | 1.586 |
| FU | 0.2547 |
| CYP1A2-inh | 0.238 |
| CYP1A2-sub | 0.171 |
| CYP2c19-inh | 0.051 |
| CYP2c19-sub | 0.808 |
| CYP2c9-inh | 0.04 |
| CYP2c9-sub | 0.813 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.794 |
| CYP3a4-inh | 0.123 |
| CYP3a4-sub | 0.293 |
| CL | 8.186 |
| T12 | 0.334 |
| hERG | 0.014 |
| Ames | 0.013 |
| ROA | 0.015 |
| SkinSen | 0.136 |
| Carcinogencity | 0.652 |
| EI | 0.956 |
| Respiratory | 0.735 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.656494 |